We have previously identified a 4% and 29% mutation rate of Smad4 and Fat1 in HNSCC tissue samples, respectively, which are in agreement with the TCGA tumor database, the results of 4MOSCs analysis and the findings in present study [2,20,21]. This evidence concerns the gene SMAD4 and neoplasm.